ADPT vs JNJ: Which Stock is Better?
Side-by-side comparison of Adaptive Biotechnologies Corp and Johnson & Johnson in 2026
ADPT
Adaptive Biotechnologies Corp
—
JNJ
Johnson & Johnson
$259.10
Key Metrics Comparison
| Metric | ADPT | JNJ | Winner |
|---|---|---|---|
| Market Cap | $2.69B | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ADPT
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADPT or JNJ a better investment?
Comparing ADPT and JNJ: Adaptive Biotechnologies Corp has a market cap of $2.69B while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADPT and JNJ?
ADPT (Adaptive Biotechnologies Corp) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADPT or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADPT or JNJ?
Both ADPT and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ADPT or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ADPT or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $2.69B for ADPT.
Should I buy ADPT or JNJ in 2026?
Both ADPT and JNJ have investment merit. ADPT trades at $N/A while JNJ trades at $259.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADPT and JNJ stock?
Key differences: Market Cap ($2.69B vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ADPT or JNJ in 2026?
The choice between ADPT and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ADPT and JNJ?
ADPT (Adaptive Biotechnologies Corp) has a market cap of $2.69B, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.